SYMNET: A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea
Sponsor
Ipsen (Industry)
Overall Status
Completed
CT.gov ID
NCT01234168
Collaborator
(none)
340
57
26
6
0.2
Study Details
Study Description
Brief Summary
The purpose of the protocol is to to assess subject's overall satisfaction regarding control of diarrhea. The study aims to supplement results obtained through clinical trials with data obtained from a population of patients receiving treatment with Somatuline Autogel in routine practice.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
340 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
An International, Cross Sectional, Non-interventional, Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea
Study Start Date
:
Oct 1, 2010
Actual Primary Completion Date
:
Dec 1, 2012
Actual Study Completion Date
:
Dec 1, 2012
Outcome Measures
Primary Outcome Measures
- Subject's overall satisfaction regarding control of diarrhea [Day of survey]
Use of questionnaires to assess patient satisfaction (Likert scale).
Secondary Outcome Measures
- Impact on daily activities of the clinical manifestations of diarrhea [Day of survey]
Use of questionnaires to assess symptom severity and impact on patient's daily activities (CGI-S).
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Out-patients 18 years of age and older, who have agreed to participate in the study
-
Diagnosed with a Neuroendocrine tumour (NET) and receiving treatment with Somatuline Autogel
Exclusion Criteria:
- Subjects for whom there are reasons that may hinder the conduct of the study (patients who have difficulty expressing themselves or who are unable to complete the questionnaires, or with insufficient data in the their files will not be enrolled in the study).
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Teaching Hospital Brno Bohunice | Brno | Czechia | ||
2 | University Hospital Hradec Kralove | Hradec Kralove | Czechia | ||
3 | Hospital Pardubice | Pardubice | Czechia | ||
4 | Teaching Hospital | Plzen | Czechia | ||
5 | Charles University | Praha | Czechia | ||
6 | Teaching Hospital Na Bulovce | Praha | Czechia | ||
7 | CHU Angers | Angers | France | 49933 | |
8 | Hôpital Avicenne | Bobigny | France | 93009 | |
9 | Hôpital Saint André | Bordeaux | France | 33075 | |
10 | CHU Trousseau | Chambray Les Tours | France | 37171 | |
11 | Hôpital Beaujon | Clichy | France | 92118 | |
12 | CHU Michallon | Grenoble | France | 38043 | |
13 | Hôpital Edouard Herriot | Lyon | France | 69437 | |
14 | CHU Timone | Marseille | France | 13385 | |
15 | Hôpital Archet 2 | Nice | France | 06202 | |
16 | Hôpital du Haut Leveque | Pessac | France | 33604 | |
17 | Hôpital Robert Debré | Reims | France | 51092 | |
18 | CHU St Etienne | Saint Priest | France | 42270 | |
19 | Hôpital Rangueil | Toulouse | France | 31059 | |
20 | Institut Gustave-Roussy | Villejuif | France | 94805 | |
21 | Semmelweis University | Budapest | Hungary | 1088 | |
22 | Karádi-Nagy Bt. | Pécs | Hungary | 7624 | |
23 | Hadasit Medical Research | Jerusalem | Israel | ||
24 | Ospedale Regina Apostolorum | Albano Laziale | Italy | ||
25 | Ospedale Pesenti Fenaroli | Alzano Lombardo | Italy | ||
26 | Ospedale Civile | Castelfranco Veneto | Italy | ||
27 | Università degli Studi di Chieti | Chieti | Italy | ||
28 | Istituti Ospedalieri di Cremona | Cremona | Italy | ||
29 | Azienda Ospedaliera-Universitaria Policlinico | Modena | Italy | ||
30 | U.O.C. Malattie dell'Apparato Digerente e del Fegato | Roma | Italy | ||
31 | Unità di Endocrinologia Istituti Fisioterapici Ospitalieri | Roma | Italy | ||
32 | Casa Sollievo della Sofferenza | San Giovanni Rotondo | Italy | ||
33 | Istituto Oncologico del Mediterraneo | Viagrande | Italy | ||
34 | Szpital Uniwersytecki im. A. Jurasza | Bydgoszcz | Poland | ||
35 | Slaskiego Uniwersytetu Medycznego | Katowice | Poland | ||
36 | Szpital Uniwersytecki w Krakowie | Krakow | Poland | ||
37 | Szpital Uniwersytecki w Lodzi | Lodz | Poland | ||
38 | Prywatna Praktyka Lekarska | Olsztyn | Poland | ||
39 | Specjalistyczny Gabinet Lekarski | Poznan | Poland | ||
40 | Samodzielny Publiczny Szpital Kliniczny Nr 1 | Szczecin | Poland | ||
41 | Niepubliczny Zaklad Opieki Zdrowotnej | Warszawa | Poland | ||
42 | Samodzielny Publiczny Centralny Szpital Kliniczny w Warszawie | Warszawa | Poland | ||
43 | Wojskowy Instytut Medyczny | Warszawa | Poland | ||
44 | Hospital De Cruces | Barakaldo | Spain | ||
45 | Hospital Universitari de Bellvitge | Barcelona | Spain | ||
46 | Hospital General Reina Sofia | Cordoba | Spain | ||
47 | Hospital Clinico Universitario de Santiago | La Coruña | Spain | ||
48 | Hospital Clinico San Carlos | Madrid | Spain | ||
49 | Hospital Xeral Cies de Vigo | Pontevedra | Spain | ||
50 | Hospital Virgen Macarena | Sevilla | Spain | ||
51 | Hospital Universitario Miguel Servet | Zaragoza | Spain | ||
52 | University Hospital of Wales | Cardiff | United Kingdom | CF14 4XN | |
53 | University Hospital | Coventry | United Kingdom | CV2 2DX | |
54 | University Hospital Aintree | Liverpool | United Kingdom | L9 7AL | |
55 | Royal Free Hospital | London | United Kingdom | ||
56 | Chrisite Hospital Institute | Manchester | United Kingdom | M204BX | |
57 | Freeman Hospital | Newcastle upon Tyne | United Kingdom | NE7 7DN |
Sponsors and Collaborators
- Ipsen
Investigators
- Study Director: Ipsen Study Director, Ipsen
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Ipsen
ClinicalTrials.gov Identifier:
NCT01234168
Other Study ID Numbers:
- 8-79-52030-736
First Posted:
Nov 4, 2010
Last Update Posted:
Nov 5, 2020
Last Verified:
Nov 1, 2020
Additional relevant MeSH terms: